Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the

Updated on: June 08,2024

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the

Updated on:June 08,2024

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Updated on: March 01,2024

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Updated on:March 01,2024

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L

Updated on: March 30,2024

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L

Updated on:March 30,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on: February 01,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on:February 01,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on: July 11,2024

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on:July 11,2024

New treatment could increase lung cancer survival

byHudson Institute of Medical ResearchMYC-expression drives platinum resistance in vivo. A Schematic overview of experimental approach. B Representative CT images of RPM mice at time-points foll

Updated on: January 13,2024

New treatment could increase lung cancer survival

byHudson Institute of Medical ResearchMYC-expression drives platinum resistance in vivo. A Schematic overview of experimental approach. B Representative CT images of RPM mice at time-points foll

Updated on:January 13,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on: April 10,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on:April 10,2024

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on: February 23,2024

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on:February 23,2024

Medical students study tampons as possible screening test for cancer

by Ileana Varela,Florida International UniversityMedical students Jessica Seigel, Leah Cohen and Lauren Dittman are hoping their study leads to a screening test for ovarian cancer. Credit: Flori

Updated on: May 13,2024

Medical students study tampons as possible screening test for cancer

by Ileana Varela,Florida International UniversityMedical students Jessica Seigel, Leah Cohen and Lauren Dittman are hoping their study leads to a screening test for ovarian cancer. Credit: Flori

Updated on:May 13,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024

Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on: July 05,2024

Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on:July 05,2024